TY - JOUR
T1 - Optogenetic methods in drug screening
T2 - technologies and applications
AU - Agus, Vivana
AU - Janovjak, Harald
PY - 2017/12/1
Y1 - 2017/12/1
N2 - The optogenetic revolution enabled spatially-precise and temporally-precise control over protein function, signaling pathway activation, and animal behavior with tremendous success in the dissection of signaling networks and neural circuits. Very recently, optogenetic methods have been paired with optical reporters in novel drug screening platforms. In these all-optical platforms, light remotely activated ion channels and kinases thereby obviating the use of electrophysiology or reagents. Consequences were remarkable operational simplicity, throughput, and cost-effectiveness that culminated in the identification of new drug candidates. These blueprints for all-optical assays also revealed potential pitfalls and inspire all-optical variants of other screens, such as those that aim at better understanding dynamic drug action or orphan protein function.
AB - The optogenetic revolution enabled spatially-precise and temporally-precise control over protein function, signaling pathway activation, and animal behavior with tremendous success in the dissection of signaling networks and neural circuits. Very recently, optogenetic methods have been paired with optical reporters in novel drug screening platforms. In these all-optical platforms, light remotely activated ion channels and kinases thereby obviating the use of electrophysiology or reagents. Consequences were remarkable operational simplicity, throughput, and cost-effectiveness that culminated in the identification of new drug candidates. These blueprints for all-optical assays also revealed potential pitfalls and inspire all-optical variants of other screens, such as those that aim at better understanding dynamic drug action or orphan protein function.
KW - optogenetics
KW - all-optical platforms
KW - kinases
KW - All-optical assays
KW - drug screening
UR - http://www.scopus.com/inward/record.url?scp=85014348153&partnerID=8YFLogxK
U2 - 10.1016/j.copbio.2017.02.006
DO - 10.1016/j.copbio.2017.02.006
M3 - Review article
C2 - 28273648
AN - SCOPUS:85014348153
SN - 0958-1669
VL - 48
SP - 8
EP - 14
JO - CURRENT OPINION IN BIOTECHNOLOGY
JF - CURRENT OPINION IN BIOTECHNOLOGY
ER -